Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-specific immune dysregulation and atherosclerosis.

Current HIV/AIDS reports - 1 Sept 2012

Zanni Markella V, Grinspoon Steven K

Abstract excerpt

HIV + patients face a heightened risk of cardiovascular disease (CVD), which cannot be fully explained by traditional risk factors or antiretroviral therapy (ART)-related cardiotoxicity. Increasing evidence suggests a significant contribution of HIV-specific immune dysregulation to atherosclerosis. HIV-specific immune dysregulation may have the following atherogenic effects: 1) activation of endothelial and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Atherosclerosis
Share to Acquired Immunodeficiency Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Genetic Predisposition to Disease

Share to Lipids

Share to Lymphocyte Activation

Share to Risk Factors

Source

Identifiers

PMID: 22638983
DOI: 10.1007/s11904-012-0123-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-specific immune dysregulation and atherosclerosis.PMID 22638983Read ↗

Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.Semantic proximity Read ↗

Vascular endothelial dysfunction in the wake of HIV and ARTSemantic proximity Read ↗

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.Semantic proximity Read ↗

Human immunodeficiency virus infection and macrophage cholesterol metabolismSemantic proximity Read ↗

HIV persists in late coronary atheroma and is associated with increased local inflammation and disease progressionSemantic proximity Read ↗

Alterations in Circulating T-Cell Subsets with Gut-Homing/Residency Phenotypes Predict HIV-1 Status and Subclinical AtherosclerosisSemantic proximity Read ↗

HIV, Inflammation, and Calcium in AtherosclerosisSemantic proximity Read ↗

Precision Phenotyping of Heart Failure in People with HIV: Early Insights and Challenges.Semantic proximity Read ↗

Cardiovascular Aging in HIV Infection: Analysis of Involved GenesSemantic proximity Read ↗

Genetic architecture of cardiometabolic risks in people living with HIVSemantic proximity Read ↗

Association of T Cell and Macrophage Activation with Arterial Vascular Health in HIVSemantic proximity Read ↗

Epigenetics, HIV, and Cardiovascular Disease Risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.